<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002020'>Gastroesophageal reflux</z:hpo> is associated with <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, but the incidence of this <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> is rising, despite widespread use of acid-suppressing medications </plain></SENT>
<SENT sid="1" pm="."><plain>This suggests that refluxed material other than acid might contribute to <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We looked for potentially carcinogenetic effects of two <z:chebi fb="1" ids="3098">bile acids</z:chebi>, <z:chebi fb="0" ids="28834">deoxycholic acid</z:chebi> (DCA) and <z:chebi fb="1" ids="9907">ursodeoxycholic acid</z:chebi> (UDCA), on Barrett's epithelial cells in vitro and in vivo </plain></SENT>
<SENT sid="3" pm="."><plain>We exposed Barrett's (BAR-T) cells to DCA or UDCA and studied the generation of reactive oxygen/nitrogen species (ROS/<z:chebi fb="0" ids="33697">RNS</z:chebi>); expression of phosphorylated H2AX (a marker of DNA damage), phosphorylated IkBα, and phosphorylated p65 (activated NF-κB pathway proteins); and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain>During endoscopy in patients, we took biopsy specimens of Barrett's mucosa before and after esophageal perfusion with DCA or UDCA and assessed DNA damage and NF-κB activation </plain></SENT>
<SENT sid="5" pm="."><plain>Exposure to DCA, but not UDCA, resulted in ROS/<z:chebi fb="0" ids="33697">RNS</z:chebi> production, DNA damage, and NF-κB activation but did not increase the rate of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in BAR-T cells </plain></SENT>
<SENT sid="6" pm="."><plain>Pretreatment with N-<z:chebi fb="9" ids="46887">acetyl</z:chebi>-l-cysteine (a ROS scavenger) prevented DNA damage after DCA exposure, and DCA did induce <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in cells treated with NF-κB inhibitors (BAY 11-7085 or AdIκB superrepressor) </plain></SENT>
<SENT sid="7" pm="."><plain>DNA damage and NF-κB activation were detected in biopsy specimens of Barrett's mucosa taken after esophageal perfusion with DCA, but not UDCA </plain></SENT>
<SENT sid="8" pm="."><plain>These data show that, in Barrett's epithelial cells, DCA induces ROS/<z:chebi fb="0" ids="33697">RNS</z:chebi> production, which causes genotoxic injury, and simultaneously induces activation of the NF-κB pathway, which enables cells with DNA damage to resist <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="9" pm="."><plain>We have demonstrated molecular mechanisms whereby <z:e sem="disease" ids="C0005403" disease_type="Disease or Syndrome" abbrv="">bile reflux</z:e> might contribute to <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
</text></document>